Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Treasury Shares (2016)

Historic Treasury Shares for Northwest Biotherapeutics (NWBO) over the last 3 years, with Q1 2011 value amounting to $480000.0.

  • Northwest Biotherapeutics' Treasury Shares changed 0.0% to $480000.0 in Q1 2011 from the same period last year, while for Mar 2011 it was $480000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $480000.0 for FY2010, which is 0.0% changed from last year.
  • Per Northwest Biotherapeutics' latest filing, its Treasury Shares stood at $8052.0 for Q4 2016.
  • Northwest Biotherapeutics' Treasury Shares' 5-year high stood at $1.6 billion during Q4 2012, with a 5-year trough of $8052.0 in Q4 2016.
  • Moreover, its 3-year median value for Treasury Shares was $1.6 million (2012), whereas its average is $312.4 million.
  • Data for Northwest Biotherapeutics' Treasury Shares shows a peak YoY increase of 9990000.0% (in 2010) and a maximum YoY decrease of 4319.53% (in 2010) over the last 5 years.
  • Over the past 3 years, Northwest Biotherapeutics' Treasury Shares (Quarter) stood at $480000.0 in 2009, then changed by 0.0% to $480000.0 in 2010, then changed by 0.0% to $480000.0 in 2011.
  • Its last three reported values are $480000.0 in Q1 2011, $480000.0 for Q4 2010, and $480000.0 during Q3 2010.